{"database": "openregs", "table": "dockets", "rows": [["FDA-2004-P-0088", "FDA", "requests that the commissioner of Food and Drug Admination determine that Astra Zenecal LP's Dyclone(dyclonine hydrochloride) Topical Solution 0.5% and 1.0%(NDA 9-925) was voluntarily withdrawn or withheld form sale for reasons other than safety or efficacy", "Nonrulemaking", "2021-09-01T01:02:10Z", "0b0000648046ee4e"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2004-P-0088"], "units": {}, "query_ms": 0.316077028401196, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}